Lung Cancer is an extremely complex and complicated disease requiring treatment that is targeted and individualized for each patient. Although outcomes and treatment options may vary, the questions that any person should ask their healthcare team are the same.
Knowledge and understanding are critical to
working with your healthcare team and to having hope.
Our Patient Handbook, “Navigating Lung Cancer, 360 Degrees of Hope,” is the first-ever comprehensive, up-to-date patient resource for Lung Cancer. First released in early 2013, your Handbook is a living document, both in print and on-line, that will have on-going updates to include the latest advancements in Lung Cancer care.
Included is valuable information about: Disease in General, Diagnosis, Specialists, Testing, Therapy, Clinical Trials, Living with Lung Cancer, Support Services.
Brought to you by generous multi-sponsored support:
The Patient Services of the Bonnie J. Addario Lung Cancer Foundation (ALCF) are based on a 360 philosophy and approach. We consider the “big picture” of patient needs and offer a comprehensive range of programs providing a road map to guide and a support system to anchor patients and their families.
We consider the “big picture” of patient needs.
Our Patient Services include:
Latest Research News
A Powerful Voice
Please don’t hesitate to reach out to us directly. You can reach our Patient Services Team at 650-598-2857. If you prefer email please write to [email protected].
Join us in person at our Lung Cancer Living Room – Bring Hope Home – A Patient Education and Support Series sessions in San Carlos, CA on the third Tuesday of every month from 5:30-7:30 pm where we BRING HOPE HOME with timely presentations by doctors, up-to-date news and your personal stories. View the calendar for more information.
If you can’t make it to our Lung Cancer Living Room – Bring Hope Home – A Patient Education and Support Series location, you can join us via Livestream remotely from home. Click here to view the USTREAM Lung Cancer Living Room – Bring Hope Home – A Patient Education and Support Series.
Our comprehensive Patient Handbook, “Navigating Lung Cancer, 360 Degrees of Hope,” is packed with valuable information. It’s the first resource of it’s kind for Lung Cancer and you can download it here.
There is much more to learn by navigating our website or visiting us in person at 1100 Industrial Rd. #1, San Carlos, CA 94070. We want you to come to ALCF for support, conversation, connection and for immediate access to knowledgeable, experienced professionals and people like you who understand the difficulties of living with Lung Cancer. We want to talk to YOU!
Join Smart Patients
We are proud to partner with Smart Patients, an online community for patients and caregivers affected by Lung Cancer and other kinds of cancer. The online support of the Smart Patients community complements our Lung Cancer Living Room and Patient Handbook, “Navigating Lung Cancer, 360 Degrees of Hope.”
Smart Patients was designed to extend the reach of these kinds of resources to an even broader group of cancer patients who can learn from each other about treatments, the latest science, and how it all fits into the context of their experience.
Discover the Latest Treatments
New lung cancer treatments such as immunotherapy and targeted treatments are being researched in clinical trials everyday Clinical trials are not only an opportunity to potentially improve patient outcomes and increase survival on an individual basis, but participation also pushes forward the science and research that we hope will make lung cancer a chronically managed disease within 10 years and ultimately a disease that is eradicated completely.
We encourage you to get involved and are proud to partner with digital health startup Antidote to make it easier than ever to connect with medical research and find opportunities to participate in these trials.
By answering a few questions using the search tool below, you can be matched to clinical trials that are right for you and in your area.
New Clinical Trial for Non-squamous Non-small Cell Lung Cancer
A new study may help answer questions about the role of immunotherapy in combination with chemotherapy in treating lung cancer patients whose disease worsened after initial response to immunotherapy. The randomized phase II study involves Taxotere® with or without Opdivo®. Eligible subjects must have advanced non-squamous non-small cell lung cancer with previous clinical benefit on treatment with single agent Opdivo. Learn more at the Hoosier Cancer Research Network website.
Talk. Test. Take Action.
Don’t Guess. Test.
ALCF is proud to partner with Lung Cancer advocacy groups across the nation to support the “Don’t Guess. Test.” movement. An initiative aimed to expand awareness and educate patients about precision medicine and the importance of comprehensive genomic testing in lung cancer. It is our hope that through this initiative, every patient with lung cancer and their families, friends and caretakers will be motivated to take action by opening a dialogue with their doctors about genomic testing to ensure all possible treatment options are explored.